Submitted by Anonymous (not verified) on 28 April 2025 - 16:36
Human medicines European public assessment report (EPAR): Hympavzi, marstacimab, Date of authorisation: 18/11/2024, Revision: 1, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Hympavzi, marstacimab, Date of authorisation: 18/11/2024, Revision: 1, Status: Authorised